#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic kidney disease Granulomatosis with polyangiitis Sickle cell disease Salivary gland cancer Angiosarcoma Mantle cell lymphoma stage III Hormone-dependent prostate cancer IPEX syndrome C3 glomerulopathy Neuropathic arthropathy Bronchopulmonary aspergillosis HER2 mutant non-small cell lung cancer Gastric cancer Neuromyelitis optica spectrum disorder Follicular lymphoma stage III More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis I – Diagnostics Familial haemophagocytic lymphohistiocytosis – Life with Disease Prader-Willi syndrome – Trials in Disease Mucopolysaccharidosis Metachromatic leukodystrophy Haemophilia B with anti factor IX – Diagnostics Friedreich’s ataxia – Basic Information Progressive multifocal leukoencephalopathy – Diagnostics Wiskott-Aldrich syndrome – Basic Information Hepatic angiosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sisunatovir INCB123667 Rp1 Etidronate Disodium Acp-204 Tartrate Tofacitinib ALLERGEN EXTRACTS Arsenic Trioxide Cibotercept Belumosudil Mesilate Gtaexs617 Volixibat Sotatercept IMB 101 Platelet Concentrate Afatinib Vixarelimab Mk-2060 Psma-11 Dostarlimab More therapies…

    Learn about Your Condition

    Familial hypertriglyceridaemia Streptococcal infection Endocrine disorder T-cell type acute leukaemia Pancoast's tumour Craniocerebral injury Angina pectoris Liver transplant Rhinitis allergic Post procedural oedema Hepatitis alcoholic Liver disorder T-cell lymphoma Pigmentary glaucoma Anxiety disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on [18F]-AlF-FAPI-74 for Staging Advanced Stomach Cancer in Patients Using PET/CT and Laparoscopy

    Recruiting

    4 1 1
    Investigated Diseases:
    • Gastric cancer
    Investigated Drugs:
    • [Al[18F]F]Fapi-74
    The Netherlands

  • Study of Lisaftoclax combined with azacitidine for elderly patients with newly diagnosed acute myeloid leukemia

    Recruiting

    3 1 1
    Investigated Drugs:
    • Azacitidine
    • Lisaftoclax
    Italy Poland Spain

  • Study of levetiracetam to prevent seizures in adults who have both Down syndrome and Alzheimer’s disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Trisomy 21
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Levetiracetam
    Spain

  • Study of TAK-360 tablets to evaluate safety and effectiveness in people with Idiopathic Hypersomnia

    Recruiting

    2 1
    France Italy Spain

  • Study on the Effectiveness and Safety of Mannan-Conjugated Allergoids for Treating Allergic Rhinitis/Rhinoconjunctivitis in Patients Allergic to House Dust Mites

    Recruiting

    3 1
    Portugal Spain

  • Study on the Effectiveness and Safety of Zasocitinib (TAK-279) for Patients with Active Psoriatic Arthritis with Previous Biologic Treatment

    Recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Zasocitinib
    France Germany Poland Spain
Previous Page
1 … 215 216 217 218 219 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!